agreed
I know everyone seems excited about this mystery client with a multi-billion dollar revenue generating product but zero guidance on revenue expectations tells me they do not know what they are doing. yes i know they gave broad stroke revenue expectations but the ranges of revenue and lack of time frames made the statements useless IMO. $3 - $20mm is a huge range and furthermore is that over 1 yr, 3 yrs, 10 yrs??? we could make $300k this yr off this wonderful new client but instead saying we are in commercialization with a company and their $3 billion product sounds alot sexier (e.g. misleading). He refused to give even conservative numbers and they wouldn't even say whether they thought we would break even this yr. WTF we were supposed to break even last year and now you have basically just told us we could expect another yr of languishing sales?
We could very well be told the same exact story each quarter. Its coming guys, these things take time, FDA trials are slow and tedious, excuse here excuse there. Again i believe the hockey stick will happen eventually but we very well may be diluted to kingdom come by the time that happens. and this management team and board will make sure they are protected against dilution but we will all get screwed. sometimes it is a race and not a marathon especially when cash burn requires infinite capital raises.
Sick of the excuses. woe is me this trial went sideways, india changed laws, zoetis pulled back on orders. If they were aggressively seeking new clients these excuses would be roadbumps but instead they were crushing. but cheers to you all who remain eternally optimistic. It will allow this mgmt team to fumble this stock back to pennyland.
News 
Market Data 
Discover 
